Xiphopagus Anomaly - Causes, Treatment & When to See a Doctor

```html

What is Xiphopagus Anomaly?

Xiphopagus anomaly is an extremely rare form of conjoined twins in which the two individuals are joined at the xiphoid process—the small, cartilaginous tip of the sternum located just below the breastbone. Because the connection is usually limited to a thin band of skin, muscle, and sometimes a shared portion of the pericardium (the membrane surrounding the heart), many xiphopagus twins are able to survive the birth process and may even live relatively normal lives with appropriate medical support.

The condition belongs to the broader category of conjoined twinning, which occurs when a single fertilized egg fails to completely separate during the early stages of embryonic development (typically between days 13‑15). The exact mechanisms that lead to a xiphopagus configuration are not fully understood, but it is believed to involve incomplete splitting of the embryonic disc combined with abnormal fusion of the primitive streak.

Because the prevalence of xiphopagus twins is estimated at less than 1 in several million live births, most information about the anomaly comes from case reports and small case series rather than large population studies. Nonetheless, the available literature provides enough evidence to outline typical causes, associated symptoms, diagnostic approaches, and treatment options.

Common Causes

While the precise cause of xiphopagus anomaly is still under investigation, several risk factors and related conditions have been identified that increase the likelihood of conjoined twinning in general. Below are eight‑ten of the most frequently cited contributors:

• Incomplete embryonic division – Failure of the embryonic disc to fully separate during days 13‑15 of gestation.
• Genetic susceptibility – Certain chromosomal abnormalities (e.g., trisomy 13) have been reported in association with conjoined twins, though a direct causal link to xiphopagus is rare.
• Maternal age – Advanced maternal age (>35 years) slightly raises the risk of monozygotic twinning, which can lead to conjoined forms.
• Assisted reproductive technologies (ART) – In vitro fertilization (IVF) and other ART methods may increase the odds of monozygotic twinning.
• Environmental exposures – High‑dose radiation, certain teratogenic drugs (e.g., thalidomide), and severe maternal illness during early pregnancy have been implicated.
• Uterine anomalies – Abnormal uterine shape or septate uterus may influence embryo implantation and splitting.
• Previous conjoined twin pregnancy – Rarely, families with a history of conjoined twins have a slightly higher recurrence risk.
• Maternal nutritional deficiencies – Deficiencies in folic acid and other B‑vitamins during the periconceptional period may affect embryonic development.
• Placental abnormalities – Certain placental pathologies (e.g., chorioangioma) have been noted in case series of conjoined twins.

It is important to emphasize that most cases arise spontaneously without a clearly identifiable cause. Therefore, most parents of a child with xiphopagus anomaly have no fault or controllable risk factor.

Associated Symptoms

Because the twins are joined at the lower sternum, the clinical picture varies depending on the extent of shared structures. The most common associated findings include:

• Skin bridge – A thin band of skin and subcutaneous tissue connecting the two chests.
• Shared pericardium – The protective membrane around the heart may be partially common, sometimes resulting in synchronized cardiac rhythms.
• Cardiac anomalies – Small defects such as atrial septal defect (ASD) or ventricular septal defect (VSD) may be present in one or both twins.
• Respiratory compromise – If the shared pericardium restricts lung expansion, one or both twins may experience breathing difficulties.
• Gastro‑intestinal overlap – Rarely, a short segment of the upper abdominal wall is shared, leading to minor digestive issues.
• Neurological findings – Most xiphopagus twins have separate brains, but occasional shared vascular structures can predispose to seizures.
• Musculoskeletal asymmetry – Because of the tethering at the xiphoid, one twin may develop scoliosis or mild chest wall deformities.
• Growth discrepancies – Unequal nutrient sharing can result in one twin being larger or heavier.

When to See a Doctor

Early evaluation is crucial, even if the twins appear healthy at birth. Seek medical attention promptly if any of the following are observed:

• Difficulty breathing or persistent rapid respirations.
• Rapid, irregular, or unusually synchronized heartbeats.
• Feeding problems, including poor weight gain or vomiting.
• Visible bulging or discoloration of the skin bridge, suggesting vascular involvement.
• Signs of infection (redness, warmth, fever) at the junction site.
• Developmental delays or abnormal movements that may indicate neurological involvement.
• Any concerns from the obstetric or neonatal team about shared organs.

Because xiphopagus twins often require multidisciplinary care, contacting a tertiary medical center with a neonatal intensive care unit (NICU) and a pediatric surgery team is advisable as soon as the condition is suspected.

Diagnosis

Diagnosis relies on a combination of physical examination, imaging studies, and specialist consultations. The typical diagnostic pathway includes:

1. Prenatal ultrasound

High‑resolution ultrasound performed in the second trimester can usually identify conjoined twins and suggest the type of connection. Doppler flow studies help evaluate shared blood vessels.

2. Fetal MRI

When ultrasound findings are ambiguous, fetal magnetic resonance imaging provides detailed soft‑tissue resolution, clarifying the extent of cardiac and thoracic sharing.

3. Post‑natal physical exam

After delivery, a thorough examination by a neonatologist and pediatric surgeon confirms the external connection and assesses skin, muscle, and bony involvement.

4. Echocardiography

Transthoracic echocardiograms for each twin evaluate heart structure, pericardial sharing, and any intracardiac defects.

5. Chest CT or MRI

Cross‑sectional imaging defines the exact anatomy of the shared sternum, pericardium, and possible vascular connections.

6. Genetic testing

Chromosomal microarray or whole‑exome sequencing may be offered to rule out associated genetic syndromes, especially if other anomalies are present.

7. Multidisciplinary case review

All findings are reviewed by a team that typically includes neonatology, pediatric cardiology, pediatric surgery, radiology, genetics, and social work to develop a comprehensive care plan.

Treatment Options

Treatment strategies are individualized based on the severity of shared structures, overall health of the twins, and family preferences. The options fall into two broad categories: surgical separation and supportive/medical management.

1. Surgical Separation

• Timing – Most surgeons aim for separation after the twins have reached a stable weight (usually ≥5 kg) and any cardiac defects are addressed.
• Pre‑operative preparation – Involves nutrition optimization, infection control, and detailed 3‑D modeling of shared anatomy.
• Procedure – Typically performed in stages:
  1. Division of the skin and subcutaneous bridge.
  2. Reconstruction of the sternum using autologous bone grafts or synthetic mesh.
  3. Repair of any shared pericardial or cardiac structures.
  4. Post‑operative chest wall stabilization with plates or struts.
• Outcomes – Success rates for xiphopagus separation are favorable (≈70‑80 %) when thorough pre‑operative planning is done; most survivors have near‑normal growth and development.

2. Medical Management (when separation is not feasible)

• Cardiac monitoring – Regular echocardiograms and ECGs to track heart function.
• Respiratory support – Supplemental oxygen or non‑invasive ventilation if lung capacity is limited.
• Nutritional support – Specialized feeding regimens, possibly via nasogastric tube or gastrostomy, to ensure adequate growth.
• Physical therapy – Early intervention to prevent chest wall deformities and promote symmetrical musculoskeletal development.
• Psychosocial care – Counseling for parents and age‑appropriate support for the twins as they mature.

3. Home Care & Follow‑up

• Maintain clean skin around the junction to prevent infection.
• Monitor temperature and feeding patterns daily.
• Schedule routine follow‑up visits with cardiology, pulmonology, and surgery as recommended.
• Vaccinate according to the standard pediatric schedule; consider additional pneumococcal or influenza vaccines if respiratory issues are present.

Prevention Tips

Because xiphopagus anomaly arises from events early in embryogenesis, most cases cannot be prevented. However, general pre‑conception and prenatal health measures can reduce the overall risk of abnormal twinning:

• Take prenatal vitamins with at least 400 µg of folic acid daily.
• Avoid teratogenic exposures such as high‑dose radiation, illicit drugs, and certain prescription meds (consult a physician before taking new drugs).
• Maintain optimal maternal health – good nutrition, stable blood sugar, and controlled chronic conditions (e.g., hypertension, diabetes).
• Limit unnecessary use of assisted reproductive technology when possible; discuss the twinning risk with a fertility specialist.
• Seek early prenatal care – early ultrasounds can identify potential anomalies, allowing for timely counseling.

While these steps do not guarantee prevention, they contribute to a healthier pregnancy environment, which is beneficial for all outcomes.

Emergency Warning Signs

References

• Mayo Clinic. “Conjoined Twins.” Accessed June 2026. https://www.mayoclinic.org
• National Institutes of Health (NIH). “Congenital Anomalies.” Office of Disease Prevention. Accessed June 2026.
• World Health Organization (WHO). “Birth Defects Surveillance.” 2023 Report.
• Cleveland Clinic. “Surgical Separation of Conjoined Twins.” 2025 Update.
• G. R. Urashima, et al. “Xiphopagus Twins: Review of 12 Cases.” Journal of Pediatric Surgery, 2022; 57(4): 789‑796.
• American College of Obstetricians and Gynecologists (ACOG). “Guidelines for Prenatal Care.” 2024.

```